DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Soquinolol
Soquinolol
Customs Tariff - Schedule
Ovid MEDLINE(R)
Pharmaceutical Appendix to the Tariff Schedule 2
Multimedia Appendix 1. Search Strategy Developed for Medline Via Ovid to Identify Existing Systematics Review. Concept 1: BP
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
(12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
Stembook 2018.Pdf
Pharmacotherapy for Mild Hypertension (Review) – the Cochrane Collaboration
(12) Patent Application Publication (10) Pub. No.: US 2004/0058896 A1 Dietrich Et Al
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) United States Patent (10) Patent No.: US 7.201923 B1 Van Lengerich (45) Date of Patent: Apr
Marrakesh Agreement Establishing the World Trade Organization
University of Groningen PET Imaging of Beta-Adrenoceptors in Human
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Review)
The Pharmacological Treatment of Arterial Hypertension in Frail, Older Patients a Systematic Review
Pharmaabkommen A1 E
Customs Tariff - Schedule Xxi - 1
Top View
Progress in the Enantioseparation of -Blockers by Chromatographic Methods
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
(12) Patent Application Publication (10) Pub. No.: US 2016/0193212 A1 Rao Et Al
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Harmonized Tariff Schedule of the United States (2006) (Rev
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
(12) United States Patent (10) Patent No.: US 8,802,850 B2 Rao Et Al
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
United States Patent (19) 11 Patent Number: 6,080,426 Amey Et Al
Identification and Characterization of Antidiabetic And
Schedule Clxxiii - European Union
(12) United States Patent (10) Patent No.: US 7,175,854 B2 Dietrich Et Al
Wo 2011/017108 A2
Beta-Blockers for Hypertension (Review)